C

Celator Pharmaceuticals

13 employees

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Diagnostics
Health Care
Medical
Pharmaceutical
Biopharma

Date founded

1999

Funding rounds raised

Total raised

$39M

from 15 investors over 15 rounds

C

Celator Pharmaceuticals raised $15M on June 26, 2014

Investors: Hercules Capital, Inc.

C

Celator Pharmaceuticals raised $39M on April 30, 2013

Investors: Valence Life Sciences and ROTH Capital Partners

C

Celator Pharmaceuticals raised $20M on September 1, 2010

Investors: Thomas, McNerney & Partners, Domain Associates, TL Ventures and Ventures West

C

Celator Pharmaceuticals raised $23M on July 29, 2008

Investors: Domain Associates, Ventures West and TL Ventures

C

Celator Pharmaceuticals raised $10M on August 3, 2007

Investors: Ventures West and Domain Associates

C

Celator Pharmaceuticals raised $20M on May 16, 2005

Investors: Domain Associates, TL Ventures and Ventures West

FAQ